Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naive Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00009256
What this trial is testing

Analysis of HIV Genetic Variation in Patients Before Beginning Highly Active Antiretroviral Therapy

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 65
Testing effectiveness (Phase 2)UnknownNCT04157699
What this trial is testing

Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis b

Who this might be right for
Chronic Hepatitis b
Qilu Pharmaceutical Co., Ltd. 100
Not applicableStudy completedNCT01726439
What this trial is testing

Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China

Who this might be right for
Chronic Hepatitis B
Bristol-Myers Squibb 3,434
Post-approval studies (Phase 4)Study completedNCT02598934
What this trial is testing

Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis

Who this might be right for
Post Menopausal Osteoporosis
Hoffmann-La Roche 308
Not applicableStudy completedNCT00086372
What this trial is testing

Long-term Follow-up of HIV Infected Patients Identified During Early Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 157
Testing effectiveness (Phase 2)Study completedNCT02413593
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 111
Testing effectiveness (Phase 2)Study completedNCT00201838
What this trial is testing

Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic NeoplasmsAdenocarcinoma
Ohio State University Comprehensive Cancer Center 38
Testing effectiveness (Phase 2)UnknownNCT05007938
What this trial is testing

Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 30
Large-scale testing (Phase 3)Study completedNCT00030654
What this trial is testing

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 21
Testing effectiveness (Phase 2)Study completedNCT00002412
What this trial is testing

MKC-442 in Combination With Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Triangle Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01004731
What this trial is testing

Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung Cancer

Who this might be right for
Stage IV Non-Small Cell Lung Cancer
University of Alabama at Birmingham 7
Testing effectiveness (Phase 2)Ended earlyNCT01440595
What this trial is testing

Grazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 5
Testing effectiveness (Phase 2)Study completedNCT03702231
What this trial is testing

Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)

Who this might be right for
Safety and TolerabilityCompare SHINGRIX Vaccine Response RatesChronic Lymphocytic Leukemia (CLL)+1 more
National Heart, Lung, and Blood Institute (NHLBI) 116
Not applicableUnknownNCT02624453
What this trial is testing

Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDS

Who this might be right for
Cryptococcal Meningitis
ANRS, Emerging Infectious Diseases 186
Large-scale testing (Phase 3)Study completedNCT00291941
What this trial is testing

Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.

Who this might be right for
Hepatitis B
Henogen 300
Post-approval studies (Phase 4)UnknownNCT00011895
What this trial is testing

Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
GlaxoSmithKline 400
Not applicableStudy completedNCT00516581
What this trial is testing

Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the HAART

Who this might be right for
HIV
UPECLIN HC FM Botucatu Unesp 376
Not applicableStudy completedNCT02758769
What this trial is testing

Long-Term Outcomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settings

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 303
Testing effectiveness (Phase 2)WithdrawnNCT00998101
What this trial is testing

Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy

Who this might be right for
Lung Cancer
UNC Lineberger Comprehensive Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT02138734
What this trial is testing

Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
ImmunityBio, Inc. 369
Next Page